370 results on '"Sanders DB"'
Search Results
2. First Data Release of the COSMOS Lyα Mapping and Tomography Observations: 3D Lyα Forest Tomography at 2.05 < z < 2.55
- Author
-
Lee, Khee-Gan, Krolewski, Alex, White, Martin, Schlegel, David, Nugent, Peter E, Hennawi, Joseph F, Müller, Thomas, Pan, Richard, Prochaska, J Xavier, Font-Ribera, Andreu, Suzuki, Nao, Glazebrook, Karl, Kacprzak, Glenn G, Kartaltepe, Jeyhan S, Koekemoer, Anton M, Le Fèvre, Olivier, Lemaux, Brian C, Maier, Christian, Nanayakkara, Themiya, Rich, R Michael, Sanders, DB, Salvato, Mara, Tasca, Lidia, and Tran, Kim-Vy H
- Subjects
Astronomical Sciences ,Physical Sciences ,intergalactic medium ,large-scale structure of universe ,quasars: absorption lines ,surveys ,techniques: spectroscopic ,astro-ph.CO ,astro-ph.GA ,Astronomical and Space Sciences ,Atomic ,Molecular ,Nuclear ,Particle and Plasma Physics ,Physical Chemistry (incl. Structural) ,Astronomy & Astrophysics ,Astronomical sciences - Abstract
Faint star-forming galaxies at z ∼ 2-3 can be used as alternative background sources to probe the Lyα forest in addition to quasars, yielding high sightline densities that enable 3D tomographic reconstruction of the foreground absorption field. Here, we present the first data release from the COSMOS Lyα Mapping And Tomography Observations (CLAMATO) Survey, which was conducted with the LRIS spectrograph on the Keck I telescope. Over an observational footprint of 0.157 deg2 within the COSMOS field, we used 240 galaxies and quasars at 2.17 < z < 3.00, with a mean comoving transverse separation of , as background sources probing the foreground Lyα forest absorption at 2.05 < z < 2.55. The Lyα forest data was then used to create a Wiener-filtered tomographic reconstruction over a comoving volume of with an effective smoothing scale of . In addition to traditional figures, this map is also presented as a virtual-reality visualization and manipulable interactive figure. We see large overdensities and underdensities that visually agree with the distribution of coeval galaxies from spectroscopic redshift surveys in the same field, including overdensities associated with several recently discovered galaxy protoclusters in the volume. Quantitatively, the map signal-to-noise is over a 3 h -1Mpc top-hat kernel based on the variances estimated from the Wiener filter. This data release includes the redshift catalog, reduced spectra, extracted Lyα forest pixel data, and reconstructed tomographic map of the absorption. These can be downloaded from Zenodo (10.5281/zenodo.1292459).
- Published
- 2018
3. C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response
- Author
-
VanDevanter, DR, primary, Heltshe, SL, additional, Skalland, M, additional, West, NE, additional, Sanders, DB, additional, Goss, CH, additional, and Flume, PA, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment
- Author
-
VanDevanter, DR, Heltshe, SL, Sanders, DB, West, NE, Skalland, M, Flume, PA, and Goss, CH
- Published
- 2021
- Full Text
- View/download PDF
5. International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
- Author
-
Narayanaswami, P, Sanders, DB, Wolfe, G, Benatar, M, Cea, G, Evoli, A, Gilhus, NE, Illa, I, Kuntz, NL, Massey, J, Melms, A, Murai, H, Nicolle, M, Palace, J, Richman, D, and Verschuuren, J
- Subjects
education - Abstract
Objective To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. Methods In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. The RAND/UCLA appropriateness method was used to develop consensus recommendations pertaining to 7 treatment topics. In February 2019, the international panel was reconvened with the addition of one member to represent South America. All previous recommendations were reviewed for currency, and new consensus recommendations were developed on topics that required inclusion or updates based on the recent literature. Up to 3 rounds of anonymous e-mail votes were used to reach consensus, with modifications to recommendations between rounds based on the panel input. A simple majority vote (80% of panel members voting "yes") was used to approve minor changes in grammar and syntax to improve clarity. Results The previous recommendations for thymectomy were updated. New recommendations were developed for the use of rituximab, eculizumab, and methotrexate as well as for the following topics: early immunosuppression in ocular MG and MG associated with immune checkpoint inhibitor treatment. Conclusion This updated formal consensus guidance of international MG experts, based on new evidence, provides recommendations to clinicians caring for patients with MG worldwide.
- Published
- 2021
6. Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
- Author
-
Hewett, K, Sanders, DB, Grove, RA, Broderick, CL, Rudo, TJ, Bassiri, A, Zvartau-Hind, M, Bril, V, Bonanno, S, Hewett, K, Sanders, D, Grove, R, Broderick, C, Rudo, T, Bassiri, A, Zvartau-Hind, M, Bril, V, and Bonanno, S
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Time Factors ,International Cooperation ,Placebo ,Antibodies, Monoclonal, Humanized ,Article ,Antibodies ,law.invention ,03 medical and health sciences ,MG, RCT, Belimumab ,0302 clinical medicine ,Randomized controlled trial ,Double-Blind Method ,law ,Internal medicine ,Activities of Daily Living ,Myasthenia Gravis ,medicine ,Clinical endpoint ,Humans ,Receptors, Cholinergic ,Generalized myasthenia ,Adverse effect ,Aged ,business.industry ,Receptor Protein-Tyrosine Kinases ,Middle Aged ,medicine.disease ,Belimumab ,Myasthenia gravis ,3. Good health ,Clinical trial ,030104 developmental biology ,Treatment Outcome ,Female ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Immunosuppressive Agents ,medicine.drug ,Follow-Up Studies - Abstract
ObjectiveTo investigate the efficacy and safety of belimumab, a fully human immunoglobulin G1λ monoclonal antibody against B-lymphocyte stimulator, in participants with generalized myasthenia gravis (MG) who remained symptomatic despite standard of care (SoC) therapy.MethodsEligible participants with MG were randomized 1:1 to receive IV belimumab 10 mg/kg or placebo in this phase II, placebo-controlled, multicenter, double-blind study (NCT01480596; BEL115123). Participants received SoC therapies throughout the 24-week treatment phase and 12-week follow-up period. The primary efficacy endpoint was mean change from baseline in the Quantitative Myasthenia Gravis (QMG) scale at week 24; safety assessments included the frequency and severity of adverse events (AEs) and serious AEs.ResultsForty participants were randomized (placebo n = 22; belimumab n = 18). The mean change in QMG score from baseline at week 24 was not significantly different for belimumab vs placebo (p = 0.256). There were no statistically significant differences between treatment groups for secondary endpoints, including the MG Composite and MG–Activity of Daily Living scores. Acetylcholine receptor antibody levels decreased over time in both treatment groups. No unexpected AEs were identified and occurrence was similar in the belimumab (78%) and placebo (91%) groups. One participant receiving placebo died (severe sepsis) during the treatment phase.ConclusionsThe primary endpoint was not met for belimumab in participants with generalized MG receiving SoC. There was no significant difference in mean change in the QMG score at week 24 for belimumab vs placebo. The safety profile of belimumab was consistent with previous systemic lupus erythematosus studies.Classification of evidenceThis study provides Class I evidence that for participants with generalized MG, belimumab did not significantly improve QMG score compared with placebo.
- Published
- 2018
7. Early determinants of lung disease in children with cystic fibrosis
- Author
-
Stanojevic, Sanja, primary, Davis, Stephanie, additional, Sanders, Db, additional, Perem, Lucy, additional, Shaw, Michelle, additional, Guido, Julia, additional, Jensen, Renee, additional, Jara, Sylvia, additional, Clem, Charles, additional, Solomon, Melina, additional, Sweezey, Neil, additional, Grasemann, Hartmut, additional, Waters, Valerie, additional, and Ratjen, Felix, additional
- Published
- 2020
- Full Text
- View/download PDF
8. Guidelines for single fiber EMG
- Author
-
Sanders, Db, Arimura, K, Cui, L, Ertaş, M, Farrugia, Me, Gilchrist, J, Kouyoumdjian, Ja, Padua, Luca, Pitt, M, Stålberg, E., Padua L (ORCID:0000-0003-2570-9326), Sanders, Db, Arimura, K, Cui, L, Ertaş, M, Farrugia, Me, Gilchrist, J, Kouyoumdjian, Ja, Padua, Luca, Pitt, M, Stålberg, E., and Padua L (ORCID:0000-0003-2570-9326)
- Abstract
This document is the consensus of international experts on the current status of Single Fiber EMG (SFEMG) and the measurement of neuromuscular jitter with concentric needle electrodes (CNE - CN-jitter). The panel of authors was chosen based on their particular interests and previous publications within a specific area of SFEMG or CN-jitter. Each member of the panel was asked to submit a section on their particular area of interest and these submissions were circulated among the panel members for edits and comments. This process continued until a consensus was reached. Donald Sanders and Erik Stålberg then edited the final document.
- Published
- 2019
9. First Data Release of the COSMOS Lyα Mapping and Tomography Observations: 3D Lyα Forest Tomography at 2.05 < z < 2.55
- Author
-
Lee, KG, Krolewski, A, White, M, Schlegel, D, Nugent, PE, Hennawi, JF, Müller, T, Pan, R, Prochaska, JX, Font-Ribera, A, Suzuki, N, Glazebrook, K, Kacprzak, GG, Kartaltepe, JS, Koekemoer, AM, Le Fèvre, O, Lemaux, BC, Maier, C, Nanayakkara, T, Rich, RM, Sanders, DB, Salvato, M, Tasca, L, and Tran, KVH
- Subjects
large-scale structure of universe ,absorption lines [quasars] ,astro-ph.GA ,Molecular ,Astronomy & Astrophysics ,Physical Chemistry ,Atomic ,Particle and Plasma Physics ,surveys ,astro-ph.CO ,Nuclear ,spectroscopic [techniques] ,intergalactic medium ,Astronomical and Space Sciences ,Physical Chemistry (incl. Structural) - Abstract
Faint star-forming galaxies at z ̃ 2-3 can be used as alternative background sources to probe the Lyα forest in addition to quasars, yielding high sightline densities that enable 3D tomographic reconstruction of the foreground absorption field. Here, we present the first data release from the COSMOS Lyα Mapping And Tomography Observations (CLAMATO) Survey, which was conducted with the LRIS spectrograph on the Keck I telescope. Over an observational footprint of 0.157 deg2 within the COSMOS field, we used 240 galaxies and quasars at 2.17 < z < 3.00, with a mean comoving transverse separation of 2.37 {h}-1 {Mpc}, as background sources probing the foreground Lyα forest absorption at 2.05 < z < 2.55. The Lyα forest data was then used to create a Wiener-filtered tomographic reconstruction over a comoving volume of 3.15 × {10}5 {h}-3 {Mpc}}3 with an effective smoothing scale of 2.5 {h}-1 {Mpc}. In addition to traditional figures, this map is also presented as a virtual-reality visualization and manipulable interactive figure. We see large overdensities and underdensities that visually agree with the distribution of coeval galaxies from spectroscopic redshift surveys in the same field, including overdensities associated with several recently discovered galaxy protoclusters in the volume. Quantitatively, the map signal-to-noise is {{S}}/{{{N}}}wiener}≈ 3.4 over a 3 h -1Mpc top-hat kernel based on the variances estimated from the Wiener filter. This data release includes the redshift catalog, reduced spectra, extracted Lyα forest pixel data, and reconstructed tomographic map of the absorption. These can be downloaded from Zenodo (10.5281/zenodo.1292459).
- Published
- 2018
10. Developing treatment guidelines for myasthenia gravis
- Author
-
Sanders, DB, Wolfe, GI, Narayanaswami, P, Illa I., and Verschuuren, Jan
- Subjects
RAND-UCLA Appropriateness Method ,myasthenia gravis ,consensus process ,treatment guidelines - Abstract
A task force of the Myasthenia Gravis Foundation of America recently published a formal consensus statement intended to be a treatment guide for clinicians caring for myasthenia gravis (MG) patients worldwide. Its development was stimulated by the fact that there is generally no accepted standard of care for MG, and no one treatment is best for all MG patients. Also, there are few randomized trials of treatments in current use, and the generalizability of the few trials that have been successful may be difficult. Fifteen international experts in MG participated in the consensus process, which used a simple consensus to develop preliminary definitions and the RAND/UCLA Appropriateness Method to quantify agreement on treatment guidance statements for seven topics: symptomatic and immunosuppressive treatment, intravenous immunoglobulin and plasma exchange, impending and manifest myasthenic crisis, thymectomy, juvenile MG, MG with muscle-specific tyrosine kinase antibodies, and MG in pregnancy. The executive summary of the guidance statement was published with open access to facilitate access by patients and healthcare professionals, and the full statement, with extensive background information, is available online. The guidance statement is a living document that will require updates as new treatments and new information on current treatments become available.
- Published
- 2018
11. DEEP NEAR-INFRARED SPECTROSCOPY OF PASSIVELY EVOLVING GALAXIES AT z greater than or similar to 1.4
- Author
-
Onodera, M, Renzini, A, Carollo, M, Cappellari, M, Mancini, C, Strazzullo, V, Daddi, E, Arimoto, N, Gobat, R, Yamada, Y, McCracken, HJ, Ilbert, O, Capak, P, Cimatti, A, Giavalisco, M, Koekemoer, AM, Kong, X, Lilly, S, Motohara, K, Ohta, K, Sanders, DB, Scoville, N, Tamura, N, Taniguchi, Y, Institute for Astronomy [Zürich], Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology in Zürich [Zürich] (ETH Zürich), INAF - Osservatorio Astronomico di Padova (OAPD), Istituto Nazionale di Astrofisica (INAF), Sub-department of Astrophysics [Oxford], Department of Physics [Oxford], University of Oxford [Oxford]-University of Oxford [Oxford], Astrophysique Interprétation Modélisation (AIM (UMR_7158 / UMR_E_9005 / UM_112)), Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences de l'Univers (INSU - CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Diderot - Paris 7 (UPD7), National Astronomical Observatory of Japan (NAOJ), Institut d'Astrophysique de Paris (IAP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Astrophysique de Marseille (LAM), Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences de l'Univers (INSU - CNRS)-Aix Marseille Université (AMU)-Centre National d'Études Spatiales [Toulouse] (CNES), Spitzer Science Center, California Institute of Technology (CALTECH), Dipartimento di Astronomia, Università di Bologna [Bologna] (UNIBO), Department of Astronomy [Amherst], University of Massachusetts [Amherst] (UMass Amherst), University of Massachusetts System (UMASS)-University of Massachusetts System (UMASS), Space Telescope Science Institute (STSci), AUTRES, Institute of Astronomy, The University of Tokyo, Division of Respiratory Medicine and Allergology, Teikyo University School of Medicine, Institute for Astronomy [Honolulu], University of Hawai‘i [Mānoa] (UHM), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), University of Oxford-University of Oxford, Astrophysique Interprétation Modélisation (AIM (UMR7158 / UMR_E_9005 / UM_112)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS), Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO), The University of Tokyo (UTokyo), Onodera, M, Renzini, A, Carollo, M, Cappellari, M, Mancini, C, Strazzullo, V, Daddi, E, Arimoto, N, Gobat, R, Yamada, Y, Mccracken, Hj, Ilbert, O, Capak, P, Cimatti, A, Giavalisco, M, Koekemoer, Am, Kong, X, Lilly, S, Motohara, K, Ohta, K, Sanders, Db, Scoville, N, Tamura, N, Taniguchi, Y, and Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)
- Subjects
[SDU.ASTR]Sciences of the Universe [physics]/Astrophysics [astro-ph] ,Astrophysics::Solar and Stellar Astrophysics ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics::Galaxy Astrophysics - Abstract
International audience; We present the results of new near-IR spectroscopic observations of passive galaxies at z greater than or similar to 1.4 in a concentration of BzK-selected galaxies in the COSMOS field. The observations have been conducted with Subaru/MOIRCS, and have resulted in absorption lines and/or continuum detection for 18 out of 34 objects. This allows us to measure spectroscopic redshifts for a sample that is almost complete to K-AB = 21. COSMOS photometric redshifts are found in fair agreement overall with the spectroscopic redshifts, with a standard deviation of similar to 0.05; however, similar to 30% of objects have photometric redshifts systematically underestimated by up to similar to 25%. We show that these systematic offsets in photometric redshifts can be removed by using these objects as a training set. All galaxies fall in four distinct redshift spikes at z = 1.43, 1.53, 1.67, and 1.82, with this latter one including seven galaxies. SED fits to broadband fluxes indicate stellar masses in the range of similar to 4-40 x 10(10) M-circle dot and that star formation was quenched similar to 1 Gyr before the cosmoic epoch at which they are observed. the spectra of several individual galaxies have allowed us to measure their H delta(F) indices and the strengths of the 4000 angstrom break, which confirms their identification as passive galaxies, as does a composite spectrum resulting from the co-addition of 17 individual spectra. The effective radii of the galaxies have been measured on the COSMOS HST/ACS i(F814W)-band image, confirming the coexistence at these redshifts of passive galaxies, which are substantially more compact than their local counterparts with others that follow the local effective radius-stellar mass relation. For the galaxy with the best signal-to-noise spectrum we were able to measure a velocity dispersion of 270 +/- 105 km s(-1) (error bar including systematic errors), indicating that this galaxy lies closely on the virial relation given its stellar mass and effective radius.
- Published
- 2012
12. Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
- Author
-
Guptill, JT, Yi, JS, Sanders, DB, Guidon, AC, Juel, VC, Massey, JM, Howard, JF, SCUDERI, FLAVIA, BARTOCCIONI, EMANUELA, EVOLI, AMELIA, Weinhold, KJ, Guptill, JT, Yi, JS, Sanders, DB, Guidon, AC, Juel, VC, Massey, JM, Howard, JF, SCUDERI, FLAVIA, BARTOCCIONI, EMANUELA, EVOLI, AMELIA, and Weinhold, KJ
- Published
- 2015
13. A Genome-wide Association Study of Myasthenia Gravis
- Author
-
Renton, Ae, Pliner, Ha, Provenzano, Carlo, Evoli, Amelia, Ricciardi, R, Nalls, Ma, Marangi, Giuseppe, Abramzon, Y, Arepalli, S, Chong, S, Hernandez, Dg, Johnson, Jo, Bartoccioni, Emanuela, Scuderi, Flavia, Maestri, M, Gibbs, Jr, Errichiello, E, Chiò, A, Restagno, G, Sabatelli, Mario, Macek, M, Scholz, Sw, Corse, A, Chaudhry, V, Benatar, M, Barohn, Rj, Mcvey, A, Pasnoor, M, Dimachkie, Mm, Rowin, J, Kissel, J, Freimer, M, Kaminski, Hj, Sanders, Db, Lipscomb, B, Massey, Jm, Chopra, M, Howard, Jf, Koopman, Wj, Nicolle, Mw, Pascuzzi, Rm, Pestronk, A, Wulf, C, Florence, J, Blackmore, D, Soloway, A, Siddiqi, Z, Muppidi, S, Wolfe, G, Richman, D, Mezei, Mm, Jiwa, T, Oger, J, Drachman, Db, Traynor, Bj, Provenzano, Carlo (ORCID:0000-0001-5476-5517), Evoli, Amelia (ORCID:0000-0003-0282-8787), Marangi, Giuseppe (ORCID:0000-0002-6898-8882), Bartoccioni, Emanuela (ORCID:0000-0002-4434-8661), Sabatelli, Mario (ORCID:0000-0001-6635-4985), Renton, Ae, Pliner, Ha, Provenzano, Carlo, Evoli, Amelia, Ricciardi, R, Nalls, Ma, Marangi, Giuseppe, Abramzon, Y, Arepalli, S, Chong, S, Hernandez, Dg, Johnson, Jo, Bartoccioni, Emanuela, Scuderi, Flavia, Maestri, M, Gibbs, Jr, Errichiello, E, Chiò, A, Restagno, G, Sabatelli, Mario, Macek, M, Scholz, Sw, Corse, A, Chaudhry, V, Benatar, M, Barohn, Rj, Mcvey, A, Pasnoor, M, Dimachkie, Mm, Rowin, J, Kissel, J, Freimer, M, Kaminski, Hj, Sanders, Db, Lipscomb, B, Massey, Jm, Chopra, M, Howard, Jf, Koopman, Wj, Nicolle, Mw, Pascuzzi, Rm, Pestronk, A, Wulf, C, Florence, J, Blackmore, D, Soloway, A, Siddiqi, Z, Muppidi, S, Wolfe, G, Richman, D, Mezei, Mm, Jiwa, T, Oger, J, Drachman, Db, Traynor, Bj, Provenzano, Carlo (ORCID:0000-0001-5476-5517), Evoli, Amelia (ORCID:0000-0003-0282-8787), Marangi, Giuseppe (ORCID:0000-0002-6898-8882), Bartoccioni, Emanuela (ORCID:0000-0002-4434-8661), and Sabatelli, Mario (ORCID:0000-0001-6635-4985)
- Abstract
Myasthenia gravis is a chronic, autoimmune, neuromuscular disease characterized by fluctuating weakness of voluntary muscle groups. Although genetic factors are known to play a role in this neuroimmunological condition, the genetic etiology underlying myasthenia gravis is not well understood.
- Published
- 2015
14. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
- Author
-
Evoli, Amelia, Guptill, Jt, Sanders, Db, Evoli, Amelia (ORCID:0000-0003-0282-8787), Evoli, Amelia, Guptill, Jt, Sanders, Db, and Evoli, Amelia (ORCID:0000-0003-0282-8787)
- Abstract
INTRODUCTION: Myasthenia gravis (MG) patients with autoantibodies to muscle-specific tyrosine kinase (MuSK) represent a distinct subset of those with this disease. Treatment and outcomes data in these patients are limited and conflicting. METHODS: We reviewed 110 MuSK-MG patients from two large clinics in Italy and the USA. RESULTS: Thirty-nine to 49% of patients with generalized, acetylcholine receptor antibody (AChR-Ab)-negative MG had MuSK-MG. Eighty-five percent were female, with disease onset typically in the fourth decade. Ocular and/or bulbar symptoms were present at onset in 79% of those studied. Eighty-five percent were MGFA class III or greater, and crisis occurred in 28%. Plasma exchange (PLEX) produced improvement in 93%, whereas only 61% improved after intravenous immunoglobulin. Long-term outcomes were comparable to those of patients with AChR-Ab-positive MG. CONCLUSIONS: MuSK-MG has a marked female predominance with frequent oculobulbar weakness and crises. Many patients deteriorate rapidly early in the disease, and PLEX is usually the preferred treatment. Long-term outcomes are similar to those of patients with AChR-Ab(+) MG.
- Published
- 2011
- Full Text
- View/download PDF
15. Galaxy interactions: The HI signature
- Author
-
Sancisi, R, Barnes, JE, Sanders, DB, and Kapteyn Astronomical Institute
- Subjects
NEUTRAL HYDROGEN OBSERVATIONS ,GAS ,DISK ,SEYFERT-GALAXY ,MOTIONS ,Astrophysics::Cosmology and Extragalactic Astrophysics ,ATOMIC-HYDROGEN ,SHELLS ,SPIRAL GALAXY ,Astrophysics::Galaxy Astrophysics ,VLA OBSERVATIONS - Abstract
HI observations are an excellent tool for investigating tidal interactions. Ongoing major and minor interactions which can lead to traumatic mergers or to accretion and the triggering of star formation, show distinct HI signatures. Interactions and mergers in the recent past can also be recognized in the HI structure and kinematics. Recent 21cm line surveys of large samples of galaxies indicate that at least one out of every four galaxies shows signs of a present interaction or merger/accretion events in the recent past.
- Published
- 1999
16. Fueling nuclear starbursts
- Author
-
Gerritsen, JPE, Icke, [No Value], Barnes, JE, Sanders, DB, and Kapteyn Astronomical Institute
- Subjects
GALAXIES ,GASDYNAMICS ,Astrophysics::Solar and Stellar Astrophysics ,Astrophysics::Earth and Planetary Astrophysics ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics::Galaxy Astrophysics - Abstract
We present a numerical simulation of two merging equal-mass, gas-rich disk galaxies. Special emphasis is given to an accurate treatment of the interstellar medium physics and star formation with its feedback. We will explain how the negative feedback from young stars restricts the bulk of the star formation during the merger-induced starburst to the nucleus.
- Published
- 1999
17. Sickle cell disease and complex congenital cardiac surgery: a case report and review of the pathophysiology and perioperative management
- Author
-
Sanders, DB, primary, Smith, BP, additional, Sowell, SR, additional, Nguyen, DH, additional, Derby, C, additional, Eshun, F, additional, and Nigro, JJ, additional
- Published
- 2013
- Full Text
- View/download PDF
18. Total artificial heart in the pediatric patient with biventricular heart failure
- Author
-
Park, SS, primary, Sanders, DB, additional, Smith, BP, additional, Ryan, J, additional, Plasencia, J, additional, Osborn, MB, additional, Wellnitz, CM, additional, Southard, RN, additional, Pierce, CN, additional, Arabia, FA, additional, Lane, J, additional, Frakes, D, additional, Velez, DA, additional, Pophal, SG, additional, and Nigro, JJ, additional
- Published
- 2013
- Full Text
- View/download PDF
19. The failing Fontan: what’s NEXT…?
- Author
-
Sanders, DB, primary, Sowell, SR, additional, Park, SS, additional, Derby, C, additional, Willis, BC, additional, Lane, JE, additional, Pierce, CN, additional, Arabia, FA, additional, Pophal, SG, additional, and Nigro, JJ, additional
- Published
- 2013
- Full Text
- View/download PDF
20. Electrophysiological methods for assessing neuromuscular transmission
- Author
-
Trontelj, J V, Sanders, DB, Stalberg, Erik, Trontelj, J V, Sanders, DB, and Stalberg, Erik
- Published
- 2002
21. Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation.
- Author
-
Sanders, DB, primary, Bittner, RC, additional, and Goss, CH, additional
- Published
- 2009
- Full Text
- View/download PDF
22. Quantitative EMG
- Author
-
Nandedkar, SD, Stålberg, Erik, Sanders, DB, Nandedkar, SD, Stålberg, Erik, and Sanders, DB
- Published
- 2001
23. Mycophenolate mofetil in myasthenia gravis: the unanswered question
- Author
-
Phan, C, primary, Sanders, DB, additional, and Siddiqi, ZA, additional
- Published
- 2008
- Full Text
- View/download PDF
24. Sickle cell disease and complex congenital cardiac surgery: a case report and review of the pathophysiology and perioperative management.
- Author
-
Sanders, DB, Smith, BP, Sowell, SR, Nguyen, DH, Derby, C, Eshun, F, and Nigro, JJ
- Subjects
- *
TOMOGRAPHY , *ANGIOGRAPHY , *ACADEMIC medical centers , *BLACK people , *BLOOD testing , *CARDIOPULMONARY bypass , *CONGENITAL heart disease , *ECHOCARDIOGRAPHY , *GENETIC polymorphisms , *HEALTH care teams , *PATHOLOGICAL physiology , *SICKLE cell anemia , *SOCIAL services case management , *EARLY medical intervention , *PERIOPERATIVE care - Abstract
Sickle cell anemia and thalassemia are hemoglobinopathies rarely encountered in the United States. Compounded with congenital heart disease, patients with sickle cell disease (SCD) requiring cardiopulmonary bypass and open-heart surgery represent the proverbial “needle in the haystack”. As such, there is some trepidation on the part of clinicians when these patients present for complex cardiac surgery.SCD is an autosomal, recessive condition that results from a single nucleotide polymorphism in the β-globin gene. Hemoglobin SS molecules (HgbSS) with this point mutation can polymerize under the right conditions, stiffening the erythrocyte membrane and distorting the cellular structure to the characteristic sickle shape. This shape change alters cellular transit through the microvasculature. As a result, circumstances such as hypoxia, hypothermia, acidosis or diminished blood flow can lead to aggregation, vascular occlusion and thrombosis. Chronically, SCD can give rise to multiorgan damage secondary to hemolysis and vascular obstruction.This review and case study details an 11-year-old African-American male with known SCD who presented to the cardiothoracic surgical service with congenital heart disease consisting of an anomalous, intramural right coronary artery arising from the left coronary sinus for surgical consultation and subsequent surgical correction. This case report will include a review of the pathophysiology and current literature regarding preoperative, intraoperative and postoperative management of SCD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. The failing Fontan: what’s NEXT…?
- Author
-
Sanders, Db, Sowell, Sr, Park, Ss, Derby, C, Willis, Bc, Lane, Je, Pierce, Cn, Arabia, Fa, Pophal, Sg, and Nigro, Jj
- Published
- 2014
- Full Text
- View/download PDF
26. Total artificial heart in the pediatric patient with biventricular heart failure.
- Author
-
Park, SS, Sanders, DB, Smith, BP, Ryan, J, Plasencia, J, Osborn, MB, Wellnitz, CM, Southard, RN, Pierce, CN, Arabia, FA, Lane, J, Frakes, D, Velez, DA, Pophal, SG, and Nigro, JJ
- Subjects
- *
LIFE support systems in critical care , *ARTIFICIAL blood circulation , *HEART transplantation , *OPERATIVE surgery , *ACADEMIC medical centers , *EXTRACORPOREAL membrane oxygenation , *HEART failure , *ARTIFICIAL hearts , *LASERS , *CASE studies , *TOMOGRAPHY , *SURGICAL equipment , *HEART assist devices , *CHILDREN - Abstract
Mechanical circulatory support emerged for the pediatric population in the late 1980s as a bridge to cardiac transplantation. The Total Artificial Heart (TAH-t) (SynCardia Systems Inc., Tuscon, AZ) has been approved for compassionate use by the Food and Drug Administration for patients with end-stage biventricular heart failure as a bridge to heart transplantation since 1985 and has had FDA approval since 2004. However, of the 1,061 patients placed on the TAH-t, only 21 (2%) were under the age 18. SynCardia Systems, Inc. recommends a minimum patient body surface area (BSA) of 1.7 m2, thus, limiting pediatric application of this device.This unique case report shares this pediatric institution’s first experience with the TAH-t. A 14-year-old male was admitted with dilated cardiomyopathy and severe biventricular heart failure. The patient rapidly decompensated, requiring extracorporeal life support. An echocardiogram revealed severe biventricular dysfunction and diffuse clot formation in the left ventricle and outflow tract. The decision was made to transition to biventricular assist device. The biventricular failure and clot formation helped guide the team to the TAH-t, in spite of a BSA (1.5 m2) below the recommendation of 1.7m2. A computed tomography (CT) scan of the thorax, in conjunction with a novel three-dimensional (3D) modeling system and team, assisted in determining appropriate fit. Chest CT and 3D modeling following implantation were utilized to determine all major vascular structures were unobstructed and the bronchi were open. The virtual 3D model confirmed appropriate device fit with no evidence of compression to the left pulmonary veins. The postoperative course was complicated by a left lung opacification. The left lung anomalies proved to be atelectasis and improved with aggressive recruitment maneuvers. The patient was supported for 11 days prior to transplantation. Chest CT and 3D modeling were crucial in assessing whether the device would fit, as well as postoperative complications in this smaller pediatric patient. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
27. Mass Structure of Sa Spirals: NGC 2179 & NGC 2775
- Author
-
Corsini, Em, Sarzi, M, Cinzano, P, Bertola, F, Pizzella, A, Persic, M, Salucci, Paolo, BE Barnes JE, and Sanders, Db
- Subjects
Settore FIS/05 - Astronomia e Astrofisica - Abstract
Recent analysis of extended rotation curves of late-type spirals have confirmed that these objects have detectable amounts of dark matter (DM) already in the optical region, with dark-to-luminous mass ratio scaling inversely with luminosity. Since currently available rotation curves of early-type spirals are often fragmentary and not extended enough, the question remains open as to whether dark halos are unequivocally present in Sa galaxies. To address this point we have observed a sample of 7 SA's measuring major axis velocities and velocity dispersion for both stars and ionized gas. Here we present results for two objects, NGC 2179 and NGC 2775. We have constructed detailed dynamical models which, for each galaxy, explain the observed kinematics for both stellar and gaseous component and which are consistent with observed photometry. The best fit model for NGC 2179 involves an oblate isotropic rotator bulge, a thin exponential disk with the same mass-to-light ratio, and a pseudo-isothermal DM halo. The mass-to-light ratio in the inner galaxy was found to be M/LR = 4.5 (M/LR)⊙ reaching M/LR = 7.5 (M/LR)⊙ at the optical radius (Ropt). For NGC 2775 the best fit model involves an oblate isotropic rotator bulge and a thin exponential disk, with M/Lr = 3.5 (M/Lr)⊙, and M/Lr = 4.7 (M/Lr)⊙ respectively. No DM halo was needed to explain the data extending to 0.7 Ropt. In the inner regions the gas rotates as fast as stars but with negligible velocity dispersion. This rules out the case where the gas kinematics is dominated by random motion, and leads us to speculate we are seeing gas rotating on a non-equatorial plane, resulting from a past external acquisition, possibly from the companion galaxy NGC 2777.
- Published
- 1999
28. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
- Author
-
Guptill JT and Sanders DB
- Published
- 2010
- Full Text
- View/download PDF
29. The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
- Author
-
Burns TM, Conaway M, Sanders DB, MG Composite and MG-QOL15 Study Group, Burns, Ted M, Conaway, Mark, and Sanders, Donald B
- Published
- 2010
- Full Text
- View/download PDF
30. Peripheral neuropathy in Krabbe disease: electrodiagnostic findings.
- Author
-
Siddiqi ZA, Sanders DB, and Massey JM
- Published
- 2006
- Full Text
- View/download PDF
31. Advances in the diagnosis of neuromuscular junction disorders.
- Author
-
Meriggioli MN and Sanders DB
- Abstract
Disorders of the neuromuscular junction have a wide range of clinical presentations, which frequently poses a diagnostic challenge to evaluating clinicians. This article describes the tests used in the diagnosis of diseases of the neuromuscular junction, reviews the evidence supporting the use of each test, and proposes guidelines for their efficient utilization. A focused review of the literature was employed. Reports from four main categories of diagnostic tests (pharmacologic, electrodiagnostic, immunologic, and miscellaneous tests) were reviewed, and the sensitivity and specificity of each test in the diagnosis of specific neuromuscular junction diseases were examined. The clinical presentation determines which diagnostic tests should be utilized in individual cases of suspected neuromuscular junction disease. However, knowledge of the sensitivity and specificity of each test can help to focus the diagnostic evaluation and maximize the diagnostic yield of each test. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
32. Breast health information: messages that appeal to young women and older women of color.
- Author
-
Simonian K, Brown SE, Sanders DB, Kidd CY, Murillo VE, Garcia R, and Marks S
- Abstract
BACKGROUND: In this study, we asked women directly for their information needs and format preferences related to breast cancer education. METHODS: Thirty focus groups were conducted nationwide with young women and women of color age 40 and older. RESULTS: Women wanted breast cancer messages to convince them that they are at risk and that screening is critical and to provide clear and detailed information about breast cancer and breast cancer screening guidelines. Women preferred to receive information from health care providers and media outlets. CONCLUSIONS: Women have a variety of suggestions related to breast cancer education that can be used in the development of educational interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
33. Comparison of tumor necrosis factor-alpha effect on the expression of iNOS in macrophage and cardiac myocytes.
- Author
-
Sanders DB, Larson DF, Hunter K, Gorman M, and Yang B
- Abstract
Proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), are elevated during cardiopulmonary bypass (CPB), heart failure, and inflammatory cardiac and systemic diseases. Elevated TNF-alpha has been linked to diminished cardiac function, decreased systemic vascular resistance, as well as renal and pulmonary dysfunction. It is understood that myocardial tissues can express TNF-alpha, which results in the induction of inducible nitric oxide synthase (iNOS) leading to a significant decline in cardiac function and other direct effects. The hypothesis of this study was to determine if TNF-alpha would stimulate iNOS and its product nitric oxide (NO) similarly in immortalized macrophage and cardiac myocytes. Cultured macrophages (RAW 264.7) and cardiac myocytes (HL-1) were placed into two treatment groups and a control. The treatments included: (1) TNF-alpha and lipopolysaccharide (LPS); and (2) LPS, TNF-alpha, interleukin-1beta (IL-1beta) and interferon-gamma (IFN-gamma) incubated for 8 h. The macrophage expression of iNOS increased by 365% (p < 0.01) and its product, NO, increased proportionally. The expression of iNOS in the cardiac myocyte did not increase with TNF-alpha and LPS. However, with the addition of IFN-alpha and IL-1beta iNOS increased to 140% of control (p < 0.05). Myocyte cGMP and NO did not increase significantly with TNF-alpha treatment. This study suggests that HL-1 myocyte iNOS cannot be induced by TNF-alpha, unlike macrophage iNOS. Furthermore, the resultant cardiac dysfunction, secondary to proinflammatory cytokines effects, is regulated via diverse pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
34. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.
- Author
-
Bedlack RS, Simel DL, Bosworth H, Samsa G, Tucker-Lipscomb B, and Sanders DB
- Published
- 2005
- Full Text
- View/download PDF
35. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
- Author
-
Meriggioli MN, Ciafaloni E, Al-Hayk KA, Rowin J, Tucker-Lipscomb B, Massey JM, Sanders DB, Meriggioli, M N, Ciafaloni, E, Al-Hayk, K A, Rowin, J, Tucker-Lipscomb, B, Massey, J M, and Sanders, D B
- Published
- 2003
- Full Text
- View/download PDF
36. Clinical aspects of MuSK antibody positive seronegative MG.
- Author
-
Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A, Sanders, D B, El-Salem, K, Massey, J M, McConville, J, and Vincent, A
- Published
- 2003
- Full Text
- View/download PDF
37. Survey and analysis of 1-22 GHz spectra for the full sample of 660 AGNs north of declination-30
- Author
-
Yuri Kovalev, Nizhelsky, Na, Kovalev, Ya, Zhekanis, Gv, Bogdantsov, Av, Green, Rf, Khachikian, Ey, and Sanders, Db
38. Galaxy Evolution in the Last similar to 11 Gyrs and the Role of Mergers
- Author
-
David Sobral, Best, P., Smail, I., Geach, J., Stott, J., Matsuda, Y., Sun, Wh, Xu, Kc, Scoville, Nz, and Sanders, Db
39. Compact jets in 100 AGNs with the strongest broad-band variability of 1-22 GHz spectra in 1997-2001
- Author
-
Yuri Kovalev, Kovalev, Yy, Nizhelsky, Na, Bogdantsov, Av, Green, Rf, Khachikian, Ey, and Sanders, Db
40. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
- Author
-
Sanders DB, Aarli JA, Cutter GR, Jaretzki A 3rd, Kaminski HJ, and Phillips LH 2nd
- Published
- 2006
- Full Text
- View/download PDF
41. Short communications. Promoting breast cancer screening to women of color.
- Author
-
Simonian K, Brown SE, Sanders DB, Kidd CY, Murillo VE, Garcia R, and Marks S
- Published
- 2004
- Full Text
- View/download PDF
42. Neuroendocrine lung tumors and disorders of the neuromuscular junction.
- Author
-
Burns TM, Juel VC, Sanders DB, Phillips LH II, Burns, T M, Juel, V C, Sanders, D B, and Phillips, L H 2nd
- Published
- 1999
- Full Text
- View/download PDF
43. COSMOS2020: a panchromatic view of the universe to z 10 from two complementary catalogs
- Author
-
J. R. Weaver, O. B. Kauffmann, O. Ilbert, H. J. McCracken, A. Moneti, S. Toft, G. Brammer, M. Shuntov, I. Davidzon, B. C. Hsieh, C. Laigle, A. Anastasiou, C. K. Jespersen, J. Vinther, P. Capak, C. M. Casey, C. J. R. McPartland, B. Milvang-Jensen, B. Mobasher, D. B. Sanders, L. Zalesky, S. Arnouts, H. Aussel, J. S. Dunlop, A. Faisst, M. Franx, L. J. Furtak, J. P. U. Fynbo, K. M. L. Gould, T. R. Greve, S. Gwyn, J. S. Kartaltepe, D. Kashino, A. M. Koekemoer, V. Kokorev, O. Le Fèvre, S. Lilly, D. Masters, G. Magdis, V. Mehta, Y. Peng, D. A. Riechers, M. Salvato, M. Sawicki, C. Scarlata, N. Scoville, R. Shirley, J. D. Silverman, A. Sneppen, V. Smolc̆ić, C. Steinhardt, D. Stern, M. Tanaka, Y. Taniguchi, H. I. Teplitz, M. Vaccari, W.-H. Wang, G. Zamorani, Laboratoire d'Astrophysique de Marseille (LAM), Aix Marseille Université (AMU)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS), Institut d'Astrophysique de Paris (IAP), Institut national des sciences de l'Univers (INSU - CNRS)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Astrophysique Interprétation Modélisation (AIM (UMR_7158 / UMR_E_9005 / UM_112)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Weaver, JR [0000-0003-1614-196X], Kauffmann, OB [0000-0001-5283-4662], Ilbert, O [0000-0002-7303-4397], McCracken, HJ [0000-0002-9489-7765], Toft, S [0000-0003-3631-7176], Brammer, G [0000-0003-2680-005X], Shuntov, M [0000-0002-7087-0701], Davidzon, I [0000-0002-2951-7519], Hsieh, BC [0000-0001-5615-4904], Anastasiou, A [0000-0001-8558-7709], Jespersen, CK [0000-0002-8896-6496], Vinther, J [0000-0002-4418-752X], Capak, P [0000-0003-3578-6843], Casey, CM [0000-0002-0930-6466], McPartland, CJR [0000-0003-0639-025X], Milvang-Jensen, B [0000-0002-2281-2785], Sanders, DB [0000-0002-1233-9998], Zalesky, L [0000-0001-5680-2326], Faisst, A [0000-0002-9382-9832], Franx, M [0000-0002-8871-3026], Furtak, LJ [0000-0001-6278-032X], Fynbo, JPU [0000-0002-8149-8298], Gould, KML [0000-0003-4196-5960], Greve, TR [0000-0002-2554-1837], Gwyn, S [0000-0001-8221-8406], Kartaltepe, JS [0000-0001-9187-3605], Kashino, D [0000-0001-9044-1747], Koekemoer, AM [0000-0002-6610-2048], Kokorev, V [0000-0002-5588-9156], Le Fèvre, O [0000-0001-5891-2596], Lilly, S [0000-0002-6423-3597], Masters, D [0000-0001-5382-6138], Magdis, G [0000-0002-4872-2294], Mehta, V [0000-0001-7166-6035], Riechers, DA [0000-0001-9585-1462], Salvato, M [0000-0001-7116-9303], Sawicki, M [0000-0002-7712-7857], Scarlata, C [0000-0002-9136-8876], Scoville, N [0000-0002-0438-3323], Shirley, R [0000-0002-1114-0135], Sneppen, A [0000-0002-5460-6126], Smolc̆ić, V [0000-0002-3893-8614], Steinhardt, C [0000-0003-3780-6801], Stern, D [0000-0003-2686-9241], Tanaka, M [0000-0002-5011-5178], Taniguchi, Y [0000-0003-2247-3741], Teplitz, HI [0000-0002-7064-5424], Vaccari, M [0000-0002-6748-0577], Wang, W-H [0000-0003-2588-1265], Zamorani, G [0000-0002-2318-301X], and Apollo - University of Cambridge Repository
- Subjects
Cosmology and Nongalactic Astrophysics (astro-ph.CO) ,Astrophysics - astrophysics of galaxies ,Astrophysics - cosmology and nongalactic astrophysics ,FOS: Physical sciences ,5109 Space Sciences ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Galaxies and Cosmology ,Universe ,panchromatic view ,Astrophysics::Solar and Stellar Astrophysics ,Astrophysics::Galaxy Astrophysics ,[SDU.ASTR]Sciences of the Universe [physics]/Astrophysics [astro-ph] ,Astrophysics::Instrumentation and Methods for Astrophysics ,Astronomy and Astrophysics ,Space and Planetary Science ,[SDU]Sciences of the Universe [physics] ,Astrophysics of Galaxies (astro-ph.GA) ,Astrophysics::Earth and Planetary Astrophysics ,51 Physical Sciences - Abstract
The Cosmic Evolution Survey (COSMOS) has become a cornerstone of extragalactic astronomy. Since the last public catalog in 2015, a wealth of new imaging and spectroscopic data has been collected in the COSMOS field. This paper describes the collection, processing, and analysis of this new imaging data to produce a new reference photometric redshift catalog. Source detection and multi-wavelength photometry is performed for 1.7 million sources across the $2\,\mathrm{deg}^{2}$ of the COSMOS field, $\sim$966,000 of which are measured with all available broad-band data using both traditional aperture photometric methods and a new profile-fitting photometric extraction tool, The Farmer, which we have developed. A detailed comparison of the two resulting photometric catalogs is presented. Photometric redshifts are computed for all sources in each catalog utilizing two independent photometric redshift codes. Finally, a comparison is made between the performance of the photometric methodologies and of the redshift codes to demonstrate an exceptional degree of self-consistency in the resulting photometric redshifts. The $i, Comment: 39 pages, 21 figures, accepted for publication in The Astrophysical Journal Supplement Series. Production of IRAC mosaics are presented in Moneti et al. "Euclid Preparation: XVIII. Cosmic Dawn Survey. Spitzer observations of the Euclid deep fields and calibration fields" which has been posted simultaneously. Catalogs can be accessed online now at https://cosmos2020.calet.org
- Published
- 2022
44. THE FMOS-COSMOS SURVEY OF STAR-FORMING GALAXIES AT z similar to 1.6. I. H alpha-BASED STAR FORMATION RATES AND DUST EXTINCTION
- Author
-
Kashino, D., Silverman, J. D., Rodighiero, G., Renzini, A., Arimoto, N., Daddi, Emanuele, Lilly, S. J., Sanders, D. B., Kartaltepe, J., Zahid, H. J., Nagao, T., Sugiyama, N., Capak, P., Carollo, C. M., Chu, J., Hasinger, G., Ilbert, O., Kajisawa, M., Kewley, L. J., Koekemoer, A. M., Kovac, K., Le Fevre, O., Masters, D., Mccracken, H. J., Onodera, M., Scoville, N., Strazzullo, V., Symeonidis, M., Taniguchi, Y., Laboratoire d'Astrophysique de Marseille (LAM), Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences de l'Univers (INSU - CNRS)-Aix Marseille Université (AMU)-Centre National d'Études Spatiales [Toulouse] (CNES), European Project: 268107,EC:FP7:ERC,ERC-2010-AdG_20100224,EARLY(2011), Aix Marseille Université (AMU)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS), Kashino, D, Silverman, Jd, Rodighiero, G, Renzini, A, Arimoto, N, Daddi, E, Lilly, Sj, Sanders, Db, Kartaltepe, J, Zahid, Hj, Nagao, T, Sugiyama, N, Capak, P, Carollo, Cm, Chu, J, Hasinger, G, Ilbert, O, Kajisawa, M, Kewley, Lj, Koekemoer, Am, Kovac, K, Le Fevre, O, Masters, D, Mccracken, Hj, Onodera, M, Scoville, N, Strazzullo, V, Symeonidis, M, and Taniguchi, Y
- Subjects
Galaxies: general ,Galaxies: ISM ,Galaxies: star formation ,[SDU.ASTR.CO]Sciences of the Universe [physics]/Astrophysics [astro-ph]/Cosmology and Extra-Galactic Astrophysics [astro-ph.CO] ,Galaxies: high-redshift ,Galaxies: evolution - Abstract
International audience; We present the first results from a near-IR spectroscopic survey of the COSMOS field, using the Fiber Multi-Object Spectrograph on the Subaru telescope, designed to characterize the star-forming galaxy population at 1.4 \textless z \textless 1.7. The high-resolution mode is implemented to detect H alpha in emission between 1.6-1.8 mu m with f(H alpha) greater than or similar to 4 x 10(-17) erg cm(-2) s(-1). Here, we specifically focus on 271 sBzK-selected galaxies that yield a H alpha detection thus providing a redshift and emission line luminosity to establish the relation between star formation rate and stellar mass. With further J-band spectroscopy for 89 of these, the level of dust extinction is assessed by measuring the Balmer decrement using co-added spectra. We find that the extinction (0.6 less than or similar to A(H alpha) less than or similar to 2.5) rises with stellar mass and is elevated at high masses compared to low-redshift galaxies. Using this subset of the spectroscopic sample, we further find that the differential extinction between stellar and nebular emission E-star(B - V)/E-neb(B - V) is 0.7-0.8, dissimilar to that typically seen at low redshift. After correcting for extinction, we derive an H alpha-based main sequence with a slope (0.81 +/- 0.04) and normalization similar to previous studies at these redshifts.
- Published
- 2013
45. The XMM-Newton Wide-Field Survey in the COSMOS Field. I. Survey Description
- Author
-
Gianni Zamorani, Alexis Finoguenov, P. Vettolani, Fabrizio Fiore, N. Z. Scoville, S. Molendi, Ingo Lehmann, Vincenzo Mainieri, Giorgio Matt, Nico Cappelluti, Roberto Gilli, Stéphane Paltani, Martin Elvis, Hermann Brunner, C. M. Urry, Takamitsu Miyaji, Guenther Hasinger, Andrea Comastri, Alberto Franceschini, Richard E. Griffiths, Marcella Brusa, I. Matute, L. Tresse, David B. Sanders, Hasinger, G, Cappelluti, N, Brunner, H, Brusa, M, Comastri, A, Elvis, M, Finoguenov, A, Fiore, F, Franceschini, A, Gilli, R, Griffiths, Re, Lehmann, I, Mainieri, V, Matt, Giorgio, Matute, I, Miyaji, T, Molendi, S, Paltani, S, Sanders, Db, Scoville, N, Tresse, L, Urry, Cm, Vettolani, P, Zamorani, G., G. Hasinger, N. Cappelluti, H. Brunner, M. Brusa, A. Comastri, M. Elvi, A. Finoguenov, F. Fiore, A. Franceschini, R. Gilli, R. E. Griffith, I. Lehmann, V. Mainieri, G. Matt, I. Matute, T. Miyaji, S. Molendi, S. Paltani, D. B. Sander, N. Scoville, L. Tresse, C. M. Urry, P. Vettolani, and G. Zamorani
- Subjects
Physics ,education.field_of_study ,Active galactic nucleus ,Field (physics) ,Cosmology: Dark Matter ,Astrophysics::High Energy Astrophysical Phenomena ,Galaxies: Formation ,Population ,Astrophysics (astro-ph) ,Solid angle ,Flux ,FOS: Physical sciences ,Astronomy and Astrophysics ,Astrophysics ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Galaxy ,Square degree ,X-Rays: Galaxies ,Cosmology: Large-Scale Structure of Universe ,Cosmology: Observation ,Space and Planetary Science ,Primary (astronomy) ,Galaxies: Evolution ,education - Abstract
We present the first set of XMM-Newton EPIC observations in the 2 square degree COSMOS field. The strength of the COSMOS project is the unprecedented combination of a large solid angle and sensitivity over the whole multiwavelength spectrum. The XMM-Newton observations are very efficient in localizing and identifying active galactic nuclei (AGN) and clusters as well as groups of galaxies. One of the primary goals of the XMM-Newton Cosmos survey is to study the co-evolution of active galactic nuclei as a function of their environment in the Cosmic web. Here we present the log of observations, images and a summary of first research highlights for the first pass of 25 XMM-Newton pointings across the field. In the existing dataset we have detected 1416 new X-ray sources in the 0.5-2, 2-4.5 and 4.5-10 keV bands to an equivalent 0.5-2 keV flux limit of 7x10-16 erg cm-2 s-1. The number of sources is expected to grow to almost 2000 in the final coverage of the survey. From an X-ray color color analysis we identify a population of heavily obscured, partially leaky or reflecting absorbers, most of which are likely to be nearby, Compton-thick AGN., 9 pages, ApJS COSMOS Special Issue, 2007 in press. the full-resolution version is available at http://www.mpe.mpg.de/XMMCosmos/PAPERS/grh_cosmos.ps.gz
- Published
- 2007
46. Unveiling the evolution of type I AGNs in the IR (15 mu m) - As seen by ISO in the ELAIS-S1 region
- Author
-
Matute I, Gruppioni C, Pozzi R, Lari C., LA FRANCA, Fabio, Green RF, Khachikian EY, Sanders DB, Matute, I, LA FRANCA, Fabio, Gruppioni, C, Pozzi, R, and Lari, C.
- Subjects
Astrophysics::High Energy Astrophysical Phenomena ,High Energy Physics::Experiment ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics::Galaxy Astrophysics - Abstract
We present the first estimate of the evolution of type 1 AGNs in the IR (15 mum) obtained from the ELAIS survey in the S1 region. We find that the luminosity function (LF) of Type 1 AGNs at 15mum is fairly well represented by a double power-law function with a bright slope of 2.9 and a faint slope of 1.1. There is evidence for significant cosmological evolution according to a pure luminosity evolution model L-15(z)proportional to(1+z)(k), with k=3.00(-0.20)(+0.16) in a (Omega(m),Omega(Lambda))=(1.0,0.0) cosmology. This evolution is similar to what is observed at other wavebands. From the luminosity function and its evolution, we estimate a contribution of similar to 2% from Type 1. AGN to the total Cosmic Infrared Background (CIRB) at 15 mum.
- Published
- 2002
47. THE FMOS-COSMOS SURVEY OF STAR-FORMING GALAXIES ATz∼ 1.6. II. THE MASS-METALLICITY RELATION AND THE DEPENDENCE ON STAR FORMATION RATE AND DUST EXTINCTION
- Author
-
Naoshi Sugiyama, C. M. Carollo, H. J. McCracken, H. J. Zahid, G. Hasinger, Katarina Kovac, D. Masters, Cosmos Team, Masato Onodera, Anton M. Koekemoer, Yoshiaki Taniguchi, Alvio Renzini, Simon J. Lilly, Tohru Nagao, O. Le Fevre, Nick Scoville, John D. Silverman, V. Strazzullo, Daichi Kashino, Christian Maier, L. J. Kewley, E. Daddi, Giulia Rodighiero, Masaru Kajisawa, J. S. Kartaltepe, O. Ilbert, Peter Capak, Margaret J. Geller, D. B. Sanders, J. Chu, Nobuo Arimoto, Laboratoire d'Astrophysique de Marseille (LAM), Aix Marseille Université (AMU)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS), Institut d'Astrophysique de Paris (IAP), Institut national des sciences de l'Univers (INSU - CNRS)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Zahid, Hj, Kashino, D, Silverman, Jd, Kewley, Lj, Daddi, E, Renzini, A, Rodighiero, G, Nagao, T, Arimoto, N, Sanders, Db, Kartaltepe, J, Lilly, Sj, Maier, C, Geller, Mj, Capak, P, Carollo, Cm, Chu, J, Hasinger, G, Ilbert, O, Kajisawa, M, Koekemoer, Am, Kovac, K, Le Fevre, O, Masters, D, Mccracken, Hj, Onodera, M, Scoville, N, Strazzullo, V, Sugiyama, N, and Taniguchi, Y
- Subjects
Cosmology and Nongalactic Astrophysics (astro-ph.CO) ,Stellar mass ,Metallicity ,media_common.quotation_subject ,FOS: Physical sciences ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics ,galaxies: abundances ,galaxies: evolution ,galaxies: fundamental parameters ,galaxies: ISM ,Astronomy and Astrophysics ,Space and Planetary Science ,Astrophysics::Solar and Stellar Astrophysics ,Astrophysics::Galaxy Astrophysics ,media_common ,Physics ,Extinction ,Star formation ,Universe ,Redshift ,Galaxy ,[SDU]Sciences of the Universe [physics] ,Content (measure theory) ,Astrophysics::Earth and Planetary Astrophysics ,Astrophysics - Cosmology and Nongalactic Astrophysics - Abstract
We investigate the relationships between stellar mass, gas-phase oxygen abundance (metallicity), star formation rate, and dust content of star-forming galaxies at z$\sim$1.6 using Subaru/FMOS spectroscopy in the COSMOS field. The mass-metallicity relation at $z\sim1.6$ is steeper than the relation observed in the local Universe. The steeper MZ relation at $z\sim1.6$ is mainly due to evolution in the stellar mass where the MZ relation begins to turnover and flatten. This turnover mass is 1.2 dex larger at $z\sim1.6$. The most massive galaxies at $z\sim1.6$ ($\sim 10^{11}M_\odot$) are enriched to the level observed in massive galaxies in the local Universe. The mass-metallicity relation we measure at $z\sim1.6$ supports the suggestion of an empirical upper metallicity limit that does not significantly evolve with redshift. We find an anti-correlation between metallicity and star formation rate for galaxies at a fixed stellar mass at $z\sim1.6$ which is similar to trends observed in the local Universe. We do not find a relation between stellar mass, metallicity and star formation rate that is independent of redshift; our data suggest that there is redshift evolution in this relation. We examine the relation between stellar mass, metallicity and dust extinction. We find that at a fixed stellar mass dustier galaxies tend to be more metal rich. From examination of the stellar masses, metallicities, SFRs and dust extinctions we conclude that stellar mass is most closely related to dust extinction., Comment: 21 pages, 14 figures. Updated to accepted version
- Published
- 2014
48. Impact of the expanded label for elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with no F508del variant in the United States.
- Author
-
Cromwell EA, Ostrenga JS, Sanders DB, Morgan W, Castellani C, Szczesniak R, and Burgel PR
- Published
- 2024
- Full Text
- View/download PDF
49. Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.
- Author
-
Narayanaswami P and Sanders DB
- Subjects
- Humans, Myasthenia Gravis drug therapy, Mycophenolic Acid therapeutic use, Azathioprine therapeutic use, Immunosuppressive Agents therapeutic use
- Abstract
Competing Interests: The declarations of interests remain the same as in the original Article.
- Published
- 2024
- Full Text
- View/download PDF
50. Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor.
- Author
-
Sanders DB, Mayer-Hamblett N, Rosenfeld M, Polinieni D, Dasenbrook E, Szczesniak R, and Cromwell EA
- Abstract
Background: We characterized people with cystic fibrosis (CF) ineligible by genotype (not age) for currently approved CFTR modulator therapy using data from the US CF Foundation Patient Registry (CFFPR)., Methods: We summarized clinical characteristics using CFFPR data from 2017 to 2022. Annual rate of change in percent predicted of forced expiratory volume in one second (ppFEV
1 ) was estimated using generalized estimating equations., Results: A total of 2,790 individuals with CF met inclusion criteria. In 2022, 12 % were less than 6 years old, 16 % were age 6-12 years, 18 % age 12-18 years and 54 % were ≥18 years. The proportion identified as White was 74 %, 17 % Black, and 26 % as Hispanic. The median (IQR) age at diagnosis was 1.2 (0.5, 9.1) months for children and 3.1 (0.3, 17.4) years for adults. Median (IQR) ppFEV1 among children was 91.9 (80.3; 102.4) and among adults, 74.3 (52.4; 90.4). Pancreatic enzymes were prescribed for 77.8 %. Population-level average (95 % CI) rates of decline in ppFEV1 among the pancreatic insufficient population was -1.5 per year (-1.8; -1.2) for ages 6 to <11 years, -2.2 per year (-2.6; -1.8) for ages 12 to <18 years, and -1.5 per year (-1.7; -1.3) for adults., Conclusions: We describe the CFTR modulator ineligible population in the US in 2017-2022. With a growing pipeline of therapies aimed at improving CFTR function for those who cannot benefit from modulators due to ineligibility, characterization of both the size and outcomes of these populations are critical to inform optimal clinical development plans and future clinical trials., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Elizabeth Cromwell reports financial support was provided by Cystic Fibrosis Foundation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.